Page last updated: 2024-08-23

sq-11725 and Tachycardia, Ventricular

sq-11725 has been researched along with Tachycardia, Ventricular in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (20.00)18.2507
2000's5 (25.00)29.6817
2010's8 (40.00)24.3611
2020's3 (15.00)2.80

Authors

AuthorsStudies
Anastasakis, A; Bloise, R; Blom, NA; Davis, AM; Gambelli, P; Giordano, U; Keegan, R; Kukavica, D; Marino, M; Mazzanti, A; Memmi, M; Monserrat, L; Monteforte, N; Morini, M; Napolitano, C; Ortíz-Genga, M; Priori, SG; Santiago, DJ; Shimizu, W; Tomasi, L; Trancuccio, A1
Abrams, DJ; Przybylski, R1
Aziz, Z; Beaser, AD; Kohli, U; Nayak, HM2
Klug, D; Vaksmann, G1
Amoussou, M; Kambiré, Y; Konaté, L; Millogo, GR; Nebié, LV; Niakara, A; Sib, E1
Edvardsen, T; Haland, TF; Haugaa, KH; Leren, IS; Majid, E; Saberniak, J1
Tan, VH; Wong, KC; Yeo, C1
D'Angelo, L; Di Gesaro, G; Fazio, G; Fazio, M; Novo, G; Novo, S; Pipitone, S; Sutera, L; Vernuccio, D; Visconti, C1
DE Magalhaes, LP; Fagundes, A; Russo, M; Xavier, E1
Denjoy, I; Egéa, G; Guicheney, P; Lunardi, J; Roux-Buisson, N1
Brugada, P; Gebauer, R; Hindricks, G; Richter, S1
Acar, P; Delay, M; Dulac, Y1
Bloise, R; Chiaretti, A; De Rosa, G; Delogu, AB; Piastra, M; Priori, SG1
Lai, LP; Lin, JL; Lin, TK; Lin, YH1
Attali, P; Bing, J; Coron, T; Cuby, C; Gohard, R1
Massari, F; Mastropasqua, F; Passantino, A; Pitzalis, MV; Rizzon, P; Totaro, P1
Coumel, P; Denjoy, I; Grau, F; Leenhardt, A; Lucet, V; Ngoc, DD1
De Simone, L; Favilli, S; Fradella, G; Manetti, A; Pollini, I1
Alessi, SR; de Paola, AA; Leite, LR; Ponzi Pereira, KR1

Reviews

1 review(s) available for sq-11725 and Tachycardia, Ventricular

ArticleYear
Current management of inherited arrhythmia syndromes associated with the cardiac ryanodine receptor.
    Current opinion in cardiology, 2023, 07-01, Volume: 38, Issue:4

    Topics: Adrenergic beta-Antagonists; Flecainide; Humans; Mutation; Nadolol; Ryanodine Receptor Calcium Release Channel; Tachycardia, Ventricular

2023

Other Studies

19 other study(ies) available for sq-11725 and Tachycardia, Ventricular

ArticleYear
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers.
    JAMA cardiology, 2022, 05-01, Volume: 7, Issue:5

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Child; Cohort Studies; Electrocardiography; Female; Humans; Male; Nadolol; Prospective Studies; Ryanodine Receptor Calcium Release Channel; Syncope; Tachycardia, Ventricular; Young Adult

2022
Ventricular arrhythmia suppression with ivabradine in a patient with catecholaminergic polymorphic ventricular tachycardia refractory to nadolol, flecainide, and sympathectomy.
    Pacing and clinical electrophysiology : PACE, 2020, Volume: 43, Issue:5

    Topics: Adolescent; Cardiovascular Agents; Electrocardiography; Exercise Test; Flecainide; Humans; Ivabradine; Male; Nadolol; Phenotype; Sympathectomy; Tachycardia, Ventricular

2020
Efficacy of ivabradine to control ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
    Pacing and clinical electrophysiology : PACE, 2018, Volume: 41, Issue:10

    Topics: Adolescent; Anti-Arrhythmia Agents; Cardiovascular Agents; Electrocardiography; Exercise Test; Female; Flecainide; Humans; Ivabradine; Male; Nadolol; Tachycardia, Ventricular; Young Adult

2018
A large deletion in RYR2 exon 3 is associated with nadolol and flecainide refractory catecholaminergic polymorphic ventricular tachycardia.
    Pacing and clinical electrophysiology : PACE, 2019, Volume: 42, Issue:8

    Topics: Adolescent; Anti-Arrhythmia Agents; Exons; Flecainide; Gene Deletion; Humans; Male; Nadolol; Ryanodine Receptor Calcium Release Channel; Tachycardia, Ventricular

2019
Right ventricular outflow tract tachycardia worsened during pregnancy.
    The Pan African medical journal, 2015, Volume: 20

    Topics: Adult; Anti-Arrhythmia Agents; Catheter Ablation; Drug Therapy, Combination; Female; Flecainide; Hospitalization; Humans; Nadolol; Pregnancy; Pregnancy Complications, Cardiovascular; Tachycardia, Ventricular

2015
Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic polymorphic ventricular tachycardia.
    Heart rhythm, 2016, Volume: 13, Issue:2

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Drug Monitoring; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Incidence; Male; Middle Aged; Nadolol; Norway; Ryanodine Receptor Calcium Release Channel; Severity of Illness Index; Tachycardia, Ventricular; Treatment Outcome

2016
Exercise-induced syncope in a 22-year-old man.
    Heart (British Cardiac Society), 2017, Volume: 103, Issue:8

    Topics: Action Potentials; Anti-Arrhythmia Agents; DNA Mutational Analysis; Electrocardiography; Exercise; Exercise Test; Genetic Predisposition to Disease; Heart Conduction System; Heart Rate; Humans; Male; Mutation, Missense; Nadolol; Phenotype; Ryanodine Receptor Calcium Release Channel; Syncope; Tachycardia, Ventricular; Time Factors; Young Adult

2017
Sympathetic tone and ventricular tachycardia.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2008, Volume: 9, Issue:9

    Topics: Adolescent; Adrenergic beta-Antagonists; Child; Electrocardiography, Ambulatory; Heart Rate; Humans; Nadolol; Sympathetic Nervous System; Tachycardia, Ventricular

2008
Pharmacological treatment of electrical storm in cathecolaminergic polymorphic ventricular tachycardia.
    Pacing and clinical electrophysiology : PACE, 2010, Volume: 33, Issue:3

    Topics: Adolescent; Anti-Arrhythmia Agents; Atenolol; Defibrillators, Implantable; Drug Therapy, Combination; Electrocardiography; Exercise Test; Humans; Male; Nadolol; Quality of Life; Syncope; Tachycardia, Ventricular; Verapamil

2010
Germline and somatic mosaicism for a mutation of the ryanodine receptor type 2 gene: implication for genetic counselling and patient caring.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2011, Volume: 13, Issue:1

    Topics: Anti-Arrhythmia Agents; Child; Combined Modality Therapy; Defibrillators, Implantable; Female; Genetic Counseling; Germ-Line Mutation; Humans; Male; Nadolol; Pedigree; Ryanodine Receptor Calcium Release Channel; Tachycardia, Ventricular; Treatment Outcome

2011
A classic electrocardiographic manifestation of catecholaminergic polymorphic ventricular tachycardia.
    Journal of cardiovascular electrophysiology, 2012, Volume: 23, Issue:5

    Topics: Adrenergic beta-Antagonists; Child; DNA Mutational Analysis; Electrocardiography, Ambulatory; Female; Genetic Predisposition to Disease; Heart Conduction System; Humans; Mutation; Nadolol; Phenotype; Predictive Value of Tests; Ryanodine Receptor Calcium Release Channel; Tachycardia, Ventricular; Treatment Outcome

2012
[Diagnosis of adrenergic ventricular tachycardia in two homozygotic twins].
    Archives des maladies du coeur et des vaisseaux, 2003, Volume: 96, Issue:5

    Topics: Adrenergic beta-Antagonists; Child; Humans; Male; Nadolol; Receptors, Adrenergic; Tachycardia, Ventricular; Twins, Monozygotic

2003
Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol.
    Pediatric emergency care, 2004, Volume: 20, Issue:3

    Topics: Adrenergic beta-Antagonists; Brain Edema; Catecholamines; Child; Decerebrate State; Electrocardiography; Emergencies; Female; Humans; Infusions, Intravenous; Intensive Care Units, Pediatric; Nadolol; Propranolol; Ryanodine Receptor Calcium Release Channel; Syncope; Tachycardia, Ventricular; Ultrasonography

2004
Exercise-provoked bidirectional ventricular tachycardia in a young woman.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2004, Volume: 103, Issue:10

    Topics: Adolescent; Adrenergic beta-Antagonists; Exercise; Female; Humans; Nadolol; Tachycardia, Ventricular

2004
[General anesthesia in a patient with catecholaminergic polymorph ventricular tachycardia].
    Annales francaises d'anesthesie et de reanimation, 1995, Volume: 14, Issue:3

    Topics: Adult; Anesthesia, General; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Catecholamines; Electrocardiography, Ambulatory; Female; Humans; Monitoring, Intraoperative; Nadolol; Stress, Psychological; Tachycardia, Ventricular

1995
The effect of nadolol on heart rate and the standard deviation of the RR intervals.
    European heart journal, 1995, Volume: 16, Issue:2

    Topics: Adult; Aged; Electrocardiography; Electrocardiography, Ambulatory; Heart Rate; Humans; Middle Aged; Myocardial Contraction; Nadolol; Tachycardia, Ventricular; Ventricular Function, Left

1995
Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients.
    Circulation, 1995, Mar-01, Volume: 91, Issue:5

    Topics: Adrenergic beta-Antagonists; Child; Death, Sudden, Cardiac; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Long QT Syndrome; Male; Nadolol; Risk Factors; Syncope; Tachycardia, Ventricular; Time Factors

1995
[Verapamil-responsive ventricular tachycardia in small children: a case report and review of the literature].
    Cardiologia (Rome, Italy), 1999, Volume: 44, Issue:2

    Topics: Anti-Arrhythmia Agents; Child, Preschool; Drug Therapy, Combination; Echocardiography, Doppler, Color; Electrocardiography; Female; Follow-Up Studies; Humans; Nadolol; Tachycardia, Ventricular; Time Factors; Verapamil

1999
Catecholaminergic polymorphic ventricular tachycardia. An important diagnosis in children with syncope and normal heart.
    Arquivos brasileiros de cardiologia, 2001, Volume: 76, Issue:1

    Topics: Adrenergic beta-Antagonists; Child; Death, Sudden, Cardiac; Electrocardiography; Female; Follow-Up Studies; Humans; Nadolol; Syncope; Tachycardia, Ventricular

2001